RT Journal Article SR Electronic T1 Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19 JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.05.17.20104604 DO 10.1101/2020.05.17.20104604 A1 Sulaiman Somani A1 Felix Richter A1 Valentin Fuster A1 Jessica De Freitas A1 Nidhi Naik A1 Keith Sigel A1 The Mount Sinai COVID Informatics Center A1 Erwin P Bottinger A1 Matthew A. Levin A1 Zahi Fayad A1 Allan C Just A1 Alexander Charney A1 Shan Zhao A1 Benjamin S Glicksberg A1 Anuradha Lala A1 Girish N Nadkarni YR 2020 UL http://medrxiv.org/content/early/2020/05/22/2020.05.17.20104604.abstract AB Background Data on patients with coronavirus disease 2019 (COVID-19) who return to hospital after discharge are scarce. Characterization of these patients may inform post-hospitalization care.Methods and Findings Retrospective cohort study of patients with confirmed SARS-CoV-2 discharged alive from five hospitals in New York City with index hospitalization between February 27th-April 12th, 2020, with follow-up of ≥14 days. Significance was defined as P<0.05 after multiplying P by 125 study-wide comparisons. Of 2,864 discharged patients, 103 (3.6%) returned for emergency care after a median of 4.5 days, with 56 requiring inpatient readmission. The most common reason for return was respiratory distress (50%). Compared to patients who did not return, among those who returned there was a higher proportion of COPD (6.8% vs 2.9%) and hypertension (36% vs 22.1%). Patients who returned also had a shorter median length of stay (LOS) during index hospitalization (4.5 [2.9,9.1] vs. 6.7 [3.5, 11.5] days; Padjusted=0.006), and were less likely to have required intensive care on index hospitalization (5.8% vs 19%; Padjusted=0.001). A trend towards association between absence of in-hospital anticoagulation on index admission and return to hospital was also observed (20.9% vs 30.9%, Padjusted=0.064). On readmission, rates of intensive care and death were 5.8% and 3.6%, respectively.Conclusions Return to hospital after admission for COVID-19 was infrequent within 14 days of discharge. The most common cause for return was respiratory distress. Patients who returned had higher proportion of COPD and hypertension with shorter LOS on index hospitalization, and a trend towards lower rates of in-hospital treatment-dose anticoagulation. Future studies should focus on whether these comorbid conditions, longer LOS and anticoagulation are associated with reduced readmissions.Competing Interest StatementGNN is a scientific co-founder of Renalytix AI and Pensieve Health. GNN receives financial compensation as a consultant and advisory board member for RenalytixAI, and owns equity in RenalytixAI and Pensieve Health. In the past 3 years GNN has also received consulting fees from AstraZeneca, Reata, GLG Consulting, BioVie and grant support from Goldfinch Bio. SS is a scientific co-founder of and owns equity in Monogram Orthopedics.Funding StatementThis work was Supported by UL1 TR001433-05, National Center for Advancing Translational Sciences, National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndividual level data are not available for this study. Aggregate data are available in the main and supplemental tables. Please contact the corresponding author for additional data.